dissection动脉修复支架植入试验的中期结果
中位随访631天,30天和1年死亡率分别为13.0%和19.6%,新发卒中6.5%。AMDS可促进主动脉弓正向重塑并封堵假腔。
要点
- AMDS在急性DeBakey I型夹层急诊手术中安全可行。
- 30天死亡率13.0%,1年死亡率19.6%,新发卒中6.5%。
- AMDS促进主动脉弓正向重塑,假腔完全闭塞或血栓化达74%。
核心结论
- AMDS通过封堵远端吻合口假腔并扩张真腔,促进主动脉弓正向重塑,实现夹层单阶段管理。
- AMDS使用安全且可重复。
研究设计与样本
- 中位年龄62.5岁,男性67.4%,中位随访631天,1例因用于医源性夹层被排除。
主要发现
- 30天死亡率为13.0%(6/46),1年死亡率为19.6%(9/46)。
- 新发卒中发生率为6.5%(3/46)。
- 超过95%的血管灌注不良因AMDS诱导的真腔扩张而缓解,包括3例术前截瘫患者。
- 主动脉弓正向重塑发生于100%病例,假腔完全闭塞或血栓化占74%。
- 近端降胸主动脉正向重塑占77%,假腔完全闭塞或血栓化占53%。
临床怎么用
- 对于急性DeBakey I型主动脉夹层,急诊手术中植入AMDS可同时处理灌注不良并促进主动脉重塑。
- 术后需关注卒中风险,本试验中新发卒中为6.5%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The intimal flap at the distal aortic anastomosis after standard aortic dissection repair creates distal anastomotic new entry, leading to false lumen (FL) pressurization and true lumen (TL) collapse and resulting in increased mortality, malperfusion, aortic growth, and reinterventions. The Ascyrus Medical Dissection Stent (AMDS; Ascyrus Medical, Boca Raton, FL) is a hybrid prosthesis that seals and depressurizes the FL at the distal anastomosis while expanding and pressurizing the TL. METHODS: The Dissected Aorta Repair Through Stent Implantation trial is a prospective, nonrandomized, international type A dissection trial where patients with acute DeBakey I dissections were enrolled between March 2017 and January 2019. Forty-seven patients were enrolled (median age, 62.5; 67.4% men) with a median follow-up of 631 days. RESULTS: All patients underwent emergent surgical repair with successful AMDS implantation. One patient was excluded because of use in iatrogenic dissection. Overall mortality at 30 days and 1 year was 13.0% (6/46) and 19.6% (9/46), whereas new strokes occurred in 6.5% (3/46). Over 95% of vessel malperfusions resolved because of AMDS-induced TL expansion, including 3 patients with preoperative paralysis. Positive remodeling of the aortic arch occurred in 100% of cases with complete obliteration or thrombosis of the FL in 74%. In the proximal descending thoracic aorta positive remodeling occurred in 77% and complete obliteration or FL thrombosis in 53% of cases. CONCLUSIONS: AMDS facilitates single-stage management of malperfusion and induces positive remodeling of the aortic arch through effective sealing of the distal anastomotic FL, depressurization of the FL with expansion, and pressurization of the TL. Importantly the use of AMDS is safe and reproducible.
引用
- Bozso SJ, Nagendran J, Chu MWA, et al. Midterm Outcomes of the Dissected Aorta Repair Through Stent Implantation Trial. Ann Thorac Surg. 2020. PMID: 32673661. doi:10.1016/j.athoracsur.2020.05.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。